Mark Stevens

SEC CIK: 0000933482
Latest filing: Oct 27, 2023

SEC filings (opens in a new tab)

ALXN holding history

Alexion Pharmaceuticals, Inc. in every 13F filed by Mark Stevens, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALXN overview All 13F holders of ALXN Full Q3 2023 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of ALXN by Mark Stevens, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−1,323−100.0%	Sold out	Holders
Q2 2021	1,323	$243.0K	<0.1%	−90−6.4%	Reduced	Holders
Q1 2021	1,413	$216.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.